Average Co-Inventor Count = 5.70
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Protagonist Therapeutics, Inc. (26 from 32 patents)
2. Janssen Biotech, Inc. (3 from 410 patents)
3. Janssen Pharmaceutica Nv (1 from 2,078 patents)
4. Affymax, Inc. (1 from 23 patents)
5. Protaganist Therapeutics, Inc. (1 from 1 patent)
28 patents:
1. 12478617 - Lipidated peptide inhibitors of interleukin-23 receptor
2. 12234300 - Conjugated hepcidin mimetics
3. 12018057 - Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
4. 11939361 - Compositions of peptide inhibitors of Interleukin-23 receptor
5. 11884748 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
6. 11845808 - Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
7. 11840581 - α4β7 thioether peptide dimer antagonists
8. 11753443 - Conjugated hepcidin mimetics
9. 11472842 - Analogues of hepcidin mimetics with improved in vivo half lives
10. 11111272 - α4α7 peptide monomer and dimer antagonists
11. 11041000 - Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
12. 10941183 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
13. 10787490 - Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
14. 10729676 - Opioid agonist peptides and uses thereof
15. 10626146 - α4β7 thioether peptide dimer antagonists